Hidalgo M - Search Results

1

Activated epidermal growth factor receptor as a novel target in pancreatic cancer therapy.

Harsha HC, Jimeno A, Molina H, Mihalas AB, Goggins MG, Hruban RH, Schulick RD, Kamath U, Maitra A, Hidalgo M, Pandey A. Harsha HC, et al. Among authors: hidalgo m. J Proteome Res. 2008 Nov;7(11):4651-8. doi: 10.1021/pr800139r. Epub 2008 Sep 27. J Proteome Res. 2008. PMID: 18821783

2

Blockade of epidermal growth factor receptor (EGFR) activity.

Jimeno A, Hidalgo M. Jimeno A, et al. Among authors: hidalgo m. Crit Rev Oncol Hematol. 2005 Mar;53(3):179-92. doi: 10.1016/j.critrevonc.2004.10.005. Crit Rev Oncol Hematol. 2005. PMID: 15718144 Review.

3

Epidermal growth factor receptor dynamics influences response to epidermal growth factor receptor targeted agents.

Jimeno A, Rubio-Viqueira B, Amador ML, Oppenheimer D, Bouraoud N, Kulesza P, Sebastiani V, Maitra A, Hidalgo M. Jimeno A, et al. Among authors: hidalgo m. Cancer Res. 2005 Apr 15;65(8):3003-10. doi: 10.1158/0008-5472.CAN-04-3586. Cancer Res. 2005. PMID: 15833824

4

Promises and pitfalls in the prediction of antiepidermal growth factor receptor activity.

Jimeno A, Hidalgo M. Jimeno A, et al. Among authors: hidalgo m. Expert Rev Anticancer Ther. 2005 Aug;5(4):727-35. doi: 10.1586/14737140.5.4.727. Expert Rev Anticancer Ther. 2005. PMID: 16111472 Review.

5

C-fos assessment as a marker of anti-epidermal growth factor receptor effect.

Jimeno A, Kulesza P, Kincaid E, Bouaroud N, Chan A, Forastiere A, Brahmer J, Clark DP, Hidalgo M. Jimeno A, et al. Among authors: hidalgo m. Cancer Res. 2006 Feb 15;66(4):2385-90. doi: 10.1158/0008-5472.CAN-05-2882. Cancer Res. 2006. PMID: 16489045

6

Pharmacogenomics of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.

Jimeno A, Hidalgo M. Jimeno A, et al. Among authors: hidalgo m. Biochim Biophys Acta. 2006 Dec;1766(2):217-29. doi: 10.1016/j.bbcan.2006.08.008. Epub 2006 Sep 12. Biochim Biophys Acta. 2006. PMID: 17045403 Review.

7

Dual mitogen-activated protein kinase and epidermal growth factor receptor inhibition in biliary and pancreatic cancer.

Jimeno A, Rubio-Viqueira B, Amador ML, Grunwald V, Maitra A, Iacobuzio-Donahue C, Hidalgo M. Jimeno A, et al. Among authors: hidalgo m. Mol Cancer Ther. 2007 Mar;6(3):1079-88. doi: 10.1158/1535-7163.MCT-06-0448. Mol Cancer Ther. 2007. PMID: 17363501

8

Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer.

Jimeno A, Tan AC, Coffa J, Rajeshkumar NV, Kulesza P, Rubio-Viqueira B, Wheelhouse J, Diosdado B, Messersmith WA, Iacobuzio-Donahue C, Maitra A, Varella-Garcia M, Hirsch FR, Meijer GA, Hidalgo M. Jimeno A, et al. Among authors: hidalgo m. Cancer Res. 2008 Apr 15;68(8):2841-9. doi: 10.1158/0008-5472.CAN-07-5200. Cancer Res. 2008. PMID: 18413752

9

An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors.

Amador ML, Oppenheimer D, Perea S, Maitra A, Cusatis G, Iacobuzio-Donahue C, Baker SD, Ashfaq R, Takimoto C, Forastiere A, Hidalgo M. Amador ML, et al. Among authors: hidalgo m. Cancer Res. 2004 Dec 15;64(24):9139-43. doi: 10.1158/0008-5472.CAN-04-1036. Cancer Res. 2004. PMID: 15604284

10

Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer.

Jimeno A, Hidalgo M. Jimeno A, et al. Among authors: hidalgo m. Mol Cancer Ther. 2006 Apr;5(4):787-96. doi: 10.1158/1535-7163.MCT-06-0005. Mol Cancer Ther. 2006. PMID: 16648548 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,231 results

Search Page

Filters